Similar articles

• Are selective COX 2 inhibitors superior to traditional NSAIDs? Both the CLASS and VIGOR trials support the COX 2 hypothesis.

  Stover RR. Stover RR. BMJ. 2002 Jul 20;325(7356):161; author reply 161. BMJ. 2002. PMID: 12134855 No abstract available.
• [A critical evaluation of side effect data on COX-2 inhibitors].

  Pomp E. Pomp E. Tidsskr Nor Laegeforen. 2002 Feb 20;122(5):476-80. Tidsskr Nor Laegeforen. 2002. PMID: 11961974 Review. Norwegian.
• COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.

  Atkinson HG. Atkinson HG. Health News. 2002 Aug;8(8):5. Health News. 2002. PMID: 12206146 No abstract available.
• [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2003 Mar 13;145(11):60. MMW Fortschr Med. 2003. PMID: 12688204 German. No abstract available.
• COX-2 inhibitors: no pain, no heart gain?

  [No authors listed] [No authors listed] Harv Heart Lett. 2001 Dec;12(4):2-4. Harv Heart Lett. 2001. PMID: 11751079 Review. No abstract available.